Vertex's Trikafta: Addressing Drug Pricing Issues

Health activists highlight the issues with Vertex's Trikafta pricing and access, advocating for justice in cystic fibrosis care.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Competition Commission, Cystic Fibrosis, health, Health Justice Initiative., Patient Advocacy, pharmaceuticals, South Africa, Trikafta, Vertex Pharmaceuticals